Importantly, multiple studies [5,15,16] have reported that CXCL12/CXCR-4 axis activation enhances cancer cell adhesion, migration, and invasion, leading to increased metastasis, and specific blockage via neutralizing antibodies targeting CXCR4 can partly interrupt this process. The gene discussed is CXCL12; the disease is cancer.